We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Cause Found of Brain Cell Death After Stroke

By HospiMedica staff writers
Posted on 08 Jan 2004
When brain cells are deprived of oxygen and nutrients following a stroke, a special channel on those cells is activated, triggering a lethal chain reaction that causes the cells to produce large quantities of free radicals, which break down the cell's DNA and other components and ultimately result in the death of the brain cells. More...
The findings were reported in the December 26, 2003, issue of Cell.

The free radicals cause the channel, called TRPM7, to become even more active, causing massive overproduction of free radicals and the death of cells. Prior to this discovery, scientists thought the reason why brain cells died when deprived of oxygen and nutrients was due to their release of glutamate, which attaches to a channel called the NMDA receptor, located on the surface of neighboring brain cells. This causes the NMDA channel to open, allowing an influx of calcium ions into the brain cells, causing them to die. Many medications developed for treating stroke were aimed at blocking the effects of glutamate on NMDA receptors, but they failed to reduce brain damage in humans. The new findings lead researchers to believe that interfering with the activity of TRPM7 allows brain cells to survive for more than three hours without oxygen and vital nutrients.

"This is a quantum leap forward in understanding how stroke causes brain damage,” says Dr. Michael Tymianski, associate professor of surgery and physiology at the University of Toronto (Canada). "Now we can see the bigger picture of why brain cells die from stroke.”





Related Links:
U. of Toronto

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.